These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38254938)
1. Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer's Disease. Tan NA; Carpio AMA; Heller HC; Pittaras EC Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254938 [TBL] [Abstract][Full Text] [Related]
2. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120 [TBL] [Abstract][Full Text] [Related]
3. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice. Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853 [TBL] [Abstract][Full Text] [Related]
4. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study. Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845 [TBL] [Abstract][Full Text] [Related]
9. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
10. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model. Cheng XR; Zhou WX; Zhang YX Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312 [TBL] [Abstract][Full Text] [Related]
11. Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice. Timmer NM; Metaxas A; van der Stelt I; Kluijtmans LA; van Berckel BN; Verbeek MM J Alzheimers Dis; 2014; 39(1):89-101. PubMed ID: 24145381 [TBL] [Abstract][Full Text] [Related]
12. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease. Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997 [TBL] [Abstract][Full Text] [Related]
13. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition. Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688 [TBL] [Abstract][Full Text] [Related]
14. Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice. Qosa H; Mohamed LA; Batarseh YS; Alqahtani S; Ibrahim B; LeVine H; Keller JN; Kaddoumi A J Nutr Biochem; 2015 Dec; 26(12):1479-90. PubMed ID: 26344778 [TBL] [Abstract][Full Text] [Related]
15. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
16. Reduction in open field activity in the absence of memory deficits in the App Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197 [TBL] [Abstract][Full Text] [Related]
17. The effects of voluntary running on cerebrovascular morphology and spatial short-term memory in a mouse model of amyloidosis. Maliszewska-Cyna E; Vecchio LM; Thomason LAM; Oore JJ; Steinman J; Joo IL; Dorr A; McLaurin J; Sled JG; Stefanovic B; Aubert I Neuroimage; 2020 Nov; 222():117269. PubMed ID: 32818618 [TBL] [Abstract][Full Text] [Related]
18. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565 [TBL] [Abstract][Full Text] [Related]
19. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice. Tapia-Rojas C; Inestrosa NC J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990 [TBL] [Abstract][Full Text] [Related]
20. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease. Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]